Constellation Diagnostics constellation.io


Public lists: Medical Devices (6121)

Constellation Diagnostics offers an imaging system that empowers patients to conduct quick, cost-effective, full body scans every month in the privacy of their homes, or in health clubs, doctors' offices and other commercial settings. Signs of skin cancer are detected as early as possible, increasing patient survival rates. Unlike applications currently on the market, Constellation is the only solution that detects changes in moles over time - which is critical to early detection.

Constellation Diagnostics offers an imaging system that empowers patients to conduct quick, cost-effective, full body scans every month in the privacy of their homes, or in health clubs, doctors' offices and other commercial settings. Signs of skin c...Show all

Company (Alive / Active)

Phone:

Fax:

45 Prospect Street

Cambridge, 02139
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Constellation Diagnostics $0M Sep 26, 2018
See all 3 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Constellation Diagnostics Jobs

jobs by Indeed job
						search
There is no Investors data available for this company. Please select another tab.
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

SciBase

Stockholm, Sweden
IPO / Went publicSciBase is a medical technology company that develops instruments for the detection of skin cancer. The Nevisense product can detect malignant melanoma, the most dangerous form of skin cancer, directly on the skin without needing to cut away suspect moles. The product is based on comprehensive research and SciBase has conducted the largest study to date on the detection of malignant melanoma, in which Nevisense achieved excellent results.Login to see details

SciBase

Stockholm, Sweden
IPO / Went publicSciBase is a medical technology company that develops instruments for the detection of skin cancer. The Nevisense product can detect malignant melanoma, the most dangerous form of skin cancer, directly on the skin without needing to cut away suspect moles. The product is based on comprehensive research and SciBase has conducted the largest study to date on the detection of malignant melanoma, in which Nevisense achieved excellent results.Login to see details

SkinVision

Amsterdam, Netherlands
Alive / ActiveSkinVision is an awareness and tracking solution that supports individuals to find and track suspicious lesions on the skin. The personalized application helps users to take high quality pictures; the online assessment helps them understand the risk related to the mole; a personal gallery enables users to compare pictures over time as well as the ability to share photos with a dermatologist.Login to see details
See all 3 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)